53 results
8-K
EX-99.1
SRRK
Scholar Rock Holding Corp
3 Jun 24
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
4:25pm
types. Data were shared in an oral presentation during the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3 in Chicago
8-K
SRRK
Scholar Rock Holding Corp
3 Jun 24
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
4:25pm
presentation during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
A copy of the press release relating to the ASCO presentation
8-K
EX-99.2
SRRK
Scholar Rock Holding Corp
22 May 24
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
8:30am
. Presented at: World Muscle Society Congress 2020, P. 257 2 Oskoui M, et al. Presented at: 2021 Muscular Dystrophy Association Clinical & Scientific
8-K
EX-99.1
SRRK
Scholar Rock Holding Corp
7 May 24
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
7:20am
in obesity in June 2024
Updated SRK-181 clinical data selected for oral presentation at American Society of Clinical Oncology (ASCO)
New SRK-439
PRE 14A
f00y9oyd
17 Apr 24
Preliminary proxy
9:45pm
8-K
EX-99.2
9ee0qw
8 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
tdqyntmos0uiz
7 Nov 23
Results of Operations and Financial Condition
7:15am
424B5
y6yrhsu
12 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
55mydve
11 Oct 23
Prospectus supplement for primary offering
5:07pm
8-K
EX-99.2
9oi5hea7p
30 Jun 23
Regulation FD Disclosure
11:04am
8-K
EX-99.1
bipkzoh6p j7v7qpv
9 May 23
Results of Operations and Financial Condition
7:30am